home / stock / drio / drio articles
Dario selected to provide integrated approach to improve employee cardiometabolic health - including support for those taking a GLP-1 medication - ...
NEW YORK, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading small-capitalization equity research and conference provider, wil...
Demand for Dario's integrated cardiometabolic solution continues to grow as employers grappling with the surge in GLP-1 medication utilization ...
Gainers OmniLit Acquisition Corp. (NASDAQ: OLIT) jumped 53.2% to $15.53. OmniLit announced that its merger with Syntec was approved by shareholder...
Agreement names Dario as the preferred digital health provider for employer clients NEW YORK, Oct. 5, 2023 /PRNewswire/ -- DarioHealth Corp. (NASD...
News, Short Squeeze, Breakout and More Instantly...
DarioHealth (NASDAQ: DRIO) , a leader in the global digital health market, today announced two new studies presented this past weekend at the 84th Annual American Diabetes Association (“ADA”) Scientific Sessions in Orlando. According to the announcement, the first study provides an ...
Dario Demonstrates 12 Months of Sustained Healthy Behavior Change for Members Taking a GLP-1 PR Newswire New research confirms behavior change driven by Dario digital platform is sustainable for 12 month period and supports clinical results for members taking a GLP-1 A...
DarioHealth (NASDAQ: DRIO) , a leader in the global digital health market, today announced a strategic reorganization designed to streamline leadership and focus the organization on accelerating its commercialization efforts. The move reflects Dario’s commitment to bringing its innovative ...